Literature DB >> 594242

Schizophrenia succeeded by affective illness; catamnestic study and statistical enquiry.

C Sheldrick, A Jablensky, N Sartorius, M Shepherd.   

Abstract

On the basis of data derived from a long-term follow-up of 12 cases and a 2-year follow-up of the International Pilot Study of Schizophrenia it is suggested that some patients with remitting schizophrenic illnesses can subsequently present clear-cut affective disorders. The implications of these findings are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 594242     DOI: 10.1017/s0033291700006267

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

1.  Psychiatric diagnoses: the weak component of modern research.

Authors:  Jules Angst
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

2.  Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study.

Authors:  H Biehl; K Maurer; C Schubart; B Krumm; E Jung
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

3.  Syndrome shift in the long-term course of schizoaffective disorders.

Authors:  A Marneros; A Deister; A Rohde
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

4.  Psychiatric epidemiology and epidemiological psychiatry.

Authors:  M Shepherd
Journal:  Am J Public Health       Date:  1985-03       Impact factor: 9.308

5.  Course of adolescent psychotic disorder with schizoaffective episodes.

Authors:  B Lay; M H Schmidt; B Blanz
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-03       Impact factor: 4.785

6.  Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.

Authors:  B Bandelow; P Müller; W Gaebel; W Köpcke; M Linden; F Müller-Spahn; A Pietzcker; F M Reischies; J Tegeler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.